Literature DB >> 11352865

Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.

A H Wu1, A S Whittemore, L N Kolonel, F Z Stanczyk, E M John, R P Gallagher, D W West.   

Abstract

Men with higher endogenous 5alpha-reductase activity may have higher prostate cancer risk. This hypothesis raises two questions: (a) Could racial differences in 5alpha-reductase activity explain the observed racial differences in prostate cancer risk? and (b) Could a man reduce his activity level by modifying his lifestyle? To address these questions, we measured two hormonal indices of 5alpha-reductase activity [serum levels of androstane-3alpha-17beta-diol glucuronide (3alpha-diol G) and androsterone glucuronide (AG)] in healthy, older African-American, white, and Asian-American men, who are at high, intermediate, and low prostate cancer risk, respectively. We also examined associations between these metabolite levels and such lifestyle characteristics as body size and physical activity as well as select aspects of medical history and family history of prostate cancer. Men included in this cross-sectional analysis (n = 1054) had served as control subjects in a population-based case-control study of prostate cancer we conducted in California, Hawaii, and Vancouver, Canada and provided information on certain personal attributes and donated blood between March 1990 and March 1992. In this study, concentrations of 3alpha-diol G declined significantly with age and increased significantly with body mass index. Mean levels of 3alpha-diol G, adjusted for age and body mass index, were 6.1 ng/ml in African-Americans, 6.9 ng/ml in whites and 4.8 ng/ml in Asian-Americans. These differences were statistically significant (African-Americans versus whites: P < 0.01; whites versus Asian-Americans: P < 0.001). Concentrations of AG decreased significantly with age, but only in whites, and were unrelated to any of the reported personal attributes. Mean levels of AG, adjusted for age, were 44.1 ng/ml in African-Americans, 44.9 ng/ml in whites, and 37.5 ng/ml in Asian-Americans (Asian-Americans versus whites, P < 0.001). In conclusion, older African-American and white men have similar levels of these two indices of 5alpha-reductase activity, and these levels are higher than those of older Asian-American men. This difference may be related to the lower prostate cancer risk in Asian-Americans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352865

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

1.  Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.

Authors:  Jong Jin Oh; Seunghyun Park; Sang Eun Lee; Sung Kyu Hong; Sangchul Lee; Hak Min Lee; Jung Keun Lee; Jin-Nyoung Ho; Sungroh Yoon; Seok-Soo Byun
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-13       Impact factor: 4.553

2.  Body fatness and sex steroid hormone concentrations in US men: results from NHANES III.

Authors:  Sabine Rohrmann; Meredith S Shiels; David S Lopez; Nader Rifai; William G Nelson; Norma Kanarek; Eliseo Guallar; Andy Menke; Corinne E Joshu; Manning Feinleib; Siobhan Sutcliffe; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2011-06-16       Impact factor: 2.506

3.  Trends in sex hormone concentrations in US males: 1988-1991 to 1999-2004.

Authors:  S J Nyante; B I Graubard; Y Li; G M McQuillan; E A Platz; S Rohrmann; G Bradwin; K A McGlynn
Journal:  Int J Androl       Date:  2011-12-13

4.  5alpha-androstane-3alpha,17beta-diol selectively activates the canonical PI3K/AKT pathway: a bioinformatics-based evidence for androgen-activated cytoplasmic signaling.

Authors:  Mikhail G Dozmorov; Qing Yang; Adam Matwalli; Robert E Hurst; Daniel J Culkin; Bradley P Kropp; Hsueh-Kung Lin
Journal:  Genomic Med       Date:  2008-02-27

5.  Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer.

Authors:  Laurens Holmes; Wenyaw Chan; Zhidong Jiang; Doriel Ward; E James Essien; Xianglin L Du
Journal:  Cancer Control       Date:  2009-04       Impact factor: 3.302

6.  Recent changes in the clinicopathologic features of Korean men with prostate cancer: a comparison with Western populations.

Authors:  Seok-Soo Byun; Sangchul Lee; Sang Eun Lee; Eunsik Lee; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Cheryn Song; Hanjong Ahn; Young Deuk Choi; Jin Seon Cho
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

7.  Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea.

Authors:  Doejung Kim; Daeheon Choi; Ju Hyun Lim; Jong Hyun Yoon; In Gab Jeong; Dalsan You; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  Korean J Urol       Date:  2012-10-19

8.  A cross-sectional study of the association of age, race and ethnicity, and body mass index with sex steroid hormone marker profiles among men in the National Health and Nutrition Examination Survey (NHANES III).

Authors:  Jamie Ritchey; Wilfried Karmaus; Tara Sabo-Attwood; Susan E Steck; Hongmei Zhang
Journal:  BMJ Open       Date:  2012-10-06       Impact factor: 2.692

9.  Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men.

Authors:  N Kurahashi; M Iwasaki; S Sasazuki; T Otani; M Inoue; S Tsugane
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

10.  The use of exome genotyping to predict pathological Gleason score upgrade after radical prostatectomy in low-risk prostate cancer patients.

Authors:  Jong Jin Oh; Seunghyun Park; Sang Eun Lee; Sung Kyu Hong; Sangchul Lee; Gheeyoung Choe; Sungroh Yoon; Seok-Soo Byun
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.